Article

Accommodating intraocular lens platform offers benefits for presbyopic correction

An accommodating IOL offers excellent depth of focus and quality of vision with reduced dependence on glasses.

"For patients wanting presbyopic correction with a higher quality of vision, the [lens] is a better choice than a multifocal IOL, and unlike multifocal IOLs, [it] can be implanted in any eye where one would implant an aspheric or spherical monofocal IOL, including in the presence of glaucoma, age-related macular degeneration, prior RK, or Fuchs' dystrophy," said Dr. Lindstrom, founder and attending surgeon, Minnesota Eye Consultants, Minneapolis.

"However, patients must be educated that they might need to wear glasses occasionally for near vision tasks with the [lens] implanted," he added.

"As the pupil constricts in reaction to bright light and accommodation for reading, there is a myopic shift in power of the Crystalens HD of [about] –0.50 D that enhances reading, whereas when the pupil enlarges at night, the Crystalens HD refraction shifts in the hyperopic direction toward plano," Dr. Lindstrom said.

"With the Crystalens 5-0, there was a hyperopic shift in power as the pupil got smaller, and this difference explains why near acuity outcomes are better with the Crystalens HD," he said.

The quality-of-vision advantage of the Crystalens HD was seen in a study of modulation transfer function, where it exhibited a performance benefit over multifocal IOLs with testing at a 3-mm aperture, although the difference between lenses diminished at a 6-mm aperture.

"There was a concern that with power added centrally, the Crystalens HD would be associated with loss of quality of vision at distance," Dr. Lindstrom said.

"However, if anything, there is a gain in mesopic contrast sensitivity testing both with and without glare. The reason is that because although the Crystalens HD has a blended bispheric monofocal optic, it behaves similar to an aspheric monofocal lens," Dr. Lindstrom said. "It is well known that an aspheric design has a quality-of-vision benefit in a mesopic environment, and this was confirmed in clinical trials."

The lens also provides good intermediate vision, surpassing the ReZoom multifocal IOL (Abbott Medical Optics [AMO]), AcrySof ReSTOR 4.0 multifocal IOL (Alcon Laboratories), and the Tecnis diffractive multifocal IOL (AMO) based on analysis of data from the SurgiVision DataLink database.

"This benefit of the Crystalens HD is expected considering its add power is lower than that of the multifocal IOLs," Dr. Lindstrom said.

"Because it provides a good range of functional uncorrected visual acuity, the Crystalens HD has attracted many surgeons who previously favored the other multifocal IOLs among presbyopia-correcting implants, and it has become a popular choice among surgeons who do custom matching," he added. "Using the Crystalens HD combined with a diffractive multifocal IOL-either the ReSTOR or Tecnis-works well and makes good sense optically."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.